Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

EU starts review of Enhertu in HER2-ultra-low breast cancer
Pharmaphorum
Monday, August 19, 2024 - 9:56am
tags:
EMA, Europe, AstraZeneca, Daiichi Sankyo, breast cancer, Enhertu
Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived
Motley Fool
Sunday, August 18, 2024 - 9:19pm
tags:
Eli Lilly, FDA, obesity, Zepbound
Boston Scientific resubmits Silk Road merger filing, giving FTC more review time
Medtech Dive
Sunday, August 18, 2024 - 9:17pm
tags:
Medtech, Boston Scientific, M&A, Silk Road Medical, FTC
Bavarian Nordic to ramp up production of mpox vaccine
Reuters
Sunday, August 18, 2024 - 9:14pm
tags:
Bavarian Nordic, mpox, vaccines
Genentech to shut down cancer immunology department amid broader R&D rethink
Fierce Biotech
Friday, August 16, 2024 - 11:36am
tags:
Genentech, cancer immunology, Ira Mellman
Jupiter Endovascular emerges with $21m for endoportal pivotal trial
Clinical Trials Arena
Friday, August 16, 2024 - 11:35am
tags:
Medtech, Jupiter Endovascular, funding, endoportal, clinical trials
Medicare drug price cuts could have limited early impact, but grow with time
BioPharma Dive
Friday, August 16, 2024 - 11:26am
tags:
Medicare, drug pricing, Inflation Reduction Act
Pfizer, BioNTech's combo mRNA shot is latest to be defeated by influenza strain B
Fierce Biotech
Friday, August 16, 2024 - 11:25am
tags:
Pfizer, BioNTech, vaccines, MRNA, Flu, COVID-19
Mark Cuban to publish Cost Plus Drug contracts
Beckers Hospital Review
Friday, August 16, 2024 - 11:23am
tags:
Mark Cuban, Cost Plus Drugs, transparency, drug pricing
When Payers Become Producers: Inside the PBM Private-Labeling Trend
Drug Channels
Friday, August 16, 2024 - 11:21am
tags:
payers, PBMs, private labeling
Novo Nordisk to build $220 mln raw materials plant in Denmark
Reuters
Friday, August 16, 2024 - 11:20am
tags:
Novo Nordisk, Novo Nordisk Pharmatech, Denmark, drug manufacturing
Armed with Phase III win, Incyte eyes label expansion for Monjuvi
Clinical Trials Arena
Friday, August 16, 2024 - 11:19am
tags:
Incyte, clinical trials, Monjuvi, relapsed or refractory follicular lymphoma
GSK notches another Zantac win as Florida court tosses expert testimony linking heartburn drug to cancer
Fierce Pharma
Friday, August 16, 2024 - 11:18am
tags:
GSK, Zantac, legal, Florida
Mpox vaccine maker Bavarian Nordic seeks ‘critical’ EU approval for teens after WHO declares health emergency
CNBC
Friday, August 16, 2024 - 11:17am
tags:
Bavarian Nordic, mpox, Europe, vaccines, adolescents
Lykos co-founder Doblin to step down after MDMA setback
Pharmaphorum
Friday, August 16, 2024 - 11:14am
tags:
Lykos Therapeutics, Rick Doblin, MDMA, FDA
US court rules for AstraZeneca, erasing Pfizer's $107.5M jury award in patent infringement case
Fierce Pharma
Thursday, August 15, 2024 - 10:33pm
tags:
AstraZeneca, Pfizer, patents, Patent Infringement, legal, Tagrisso
Tandem warns iPhone app still draining insulin pump batteries
Medtech Dive
Thursday, August 15, 2024 - 10:27pm
tags:
Tandem Diabetes, Medtech, insulin pumps, iPhone, diabetes
'We are firing on all cylinders': Bayer pharma BD chief says group overhaul not slowing dealmaking
Fierce Biotech
Thursday, August 15, 2024 - 10:11pm
tags:
Bayer, M&A
Following rejection and retractions, Lykos caps off chaotic week by cutting 75% of staff
Fierce Biotech
Thursday, August 15, 2024 - 10:08pm
tags:
Lykos Therapeutics, layoffs, MDMA, PTSD
FDA approves AstraZeneca's non-small cell lung cancer treatment
Reuters
Thursday, August 15, 2024 - 10:06pm
tags:
AstraZeneca, Imfinzi, FDA, non-small cell lung cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.